500 Participants Needed

Non-Invasive Retinal Assessment for Retinal Disease

JK
JM
Overseen ByJan M Full, BSN
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Randy Kardon
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment LSFG-NAVI for retinal disease?

Research shows that LSFG-NAVI, a technique for measuring blood flow in the eye, is reproducible and accurate in assessing retinal circulation, which is important for conditions like glaucoma and diabetic retinopathy. This suggests it could be effective in monitoring and potentially managing retinal diseases.12345

Is laser speckle flowgraphy (LSFG) safe for humans?

Laser speckle flowgraphy (LSFG) is a non-invasive method used to measure blood flow in the eye, and it has been used safely in studies involving patients with glaucoma and other eye conditions. No specific safety concerns have been reported in the available research.12367

How is the LSFG-NAVI treatment different from other treatments for retinal disease?

LSFG-NAVI is unique because it is a non-invasive method that uses laser speckle flowgraphy to measure blood flow in the retina, allowing for precise monitoring of retinal circulation without direct contact with the eye. This makes it different from other treatments that may require invasive procedures or do not provide real-time blood flow data.13456

What is the purpose of this trial?

This study investigates a new technology to assess the structure and function inside the eye. Retinal imaging of subjects with inner and outer retinal defects to detect areas of abnormal structure and function compared to other visual function tests.

Research Team

RH

Randy H Kardon, MD, PhD

Principal Investigator

University of Iowa Department of Ophthalmology

Eligibility Criteria

This trial is for people with certain eye conditions like Ischemic Optic Neuropathy, Retinal Artery Occlusion, and Leber's Optic Atrophy. Participants should have had a normal eye exam in the last two years and can't have severe cataracts or other issues that would affect retinal imaging.

Inclusion Criteria

It seems like there might be some confusion or a mix-up in the provided criterion. The statement seems to be discussing the total number of subjects in a study and the reasons for exclusion. It mentions the need for 450 participants, including 50 controls and 400 patients. It also refers to a situation where a subject might blink too much or have difficulty focusing during an imaging test. If you need assistance with a different criterion or further clarification, please feel free to provide more details.
I have a specific eye condition affecting my vision.
I have mild cataracts or clear vision that doesn't affect detailed eye scans.
See 2 more

Exclusion Criteria

I have a cataract or eye condition that does not severely affect retina imaging.
My eyesight is affected by an abnormal retina or optic nerve.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Imaging

Retinal imaging of subjects with inner and outer retinal defects to detect areas of abnormal structure and function

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after imaging

2-4 weeks

Treatment Details

Interventions

  • LSFG-NAVI
Trial Overview The study is testing LSFG-NAVI, a new non-invasive technology to examine the retina's structure and function. It aims to identify abnormal areas by comparing this method with other visual tests in subjects with inner or outer retinal defects.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Laser Speckle Blood Flow GroupExperimental Treatment1 Intervention

LSFG-NAVI is already approved in United States, Japan for the following indications:

πŸ‡ΊπŸ‡Έ
Approved in United States as LSFG-NAVI for:
  • Assessment of retinal structure and function
  • Detection of inner and outer retinal defects
πŸ‡―πŸ‡΅
Approved in Japan as LSFG-NAVI for:
  • Assessment of retinal microcirculation
  • Diagnosis of glaucoma and other optic nerve diseases

Find a Clinic Near You

Who Is Running the Clinical Trial?

Randy Kardon

Lead Sponsor

Trials
4
Recruited
1,100+

Findings from Research

The study demonstrated that the modified laser speckle flowgraphy (LSFG-NAVI) technique has excellent intrasession reproducibility for measuring mean blur rate (MBR) in the optic disk and choroid of glaucoma patients, with high intraclass correlation coefficients (ICC) of 0.95 and 0.98, respectively.
Reproducibility was moderate for the retinal artery and vein, indicating that LSFG-NAVI is particularly reliable for assessing retinal circulation in the optic disk, which is crucial for monitoring glaucoma progression.
Reproducibility of retinal circulation measurements obtained using laser speckle flowgraphy-NAVI in patients with glaucoma.Aizawa, N., Yokoyama, Y., Chiba, N., et al.[2022]
Laser speckle flowgraphy (LSFG) demonstrated that healthy individuals have symmetrical blood flow in the fundus, indicating its potential as a reliable diagnostic tool.
In patients with internal carotid artery occlusion (ICAO), LSFG effectively detected disparities in ocular blood flow, showing high sensitivity (100%) and specificity (93.8%) for identifying ocular ischemic syndrome (OIS).
Evaluation of Fundus Blood Flow in Normal Individuals and Patients with Internal Carotid Artery Obstruction Using Laser Speckle Flowgraphy.Shinohara, Y., Kashima, T., Akiyama, H., et al.[2018]
Laser speckle flowgraphy (LSFG) is a noninvasive imaging technique that effectively visualizes and measures blood flow in the posterior part of the eye, including the retina, choroid, and optic nerve head.
This review highlights LSFG's advantages over other retinal imaging technologies and emphasizes the need for further research to enhance its diagnostic capabilities and integrate it with other methods for assessing chorioretinal circulation.
Use of the laser speckle flowgraphy in posterior fundus circulation research.Zhang, W., Kogure, A., Yamamoto, K., et al.[2012]

References

Reproducibility of retinal circulation measurements obtained using laser speckle flowgraphy-NAVI in patients with glaucoma. [2022]
Evaluation of Fundus Blood Flow in Normal Individuals and Patients with Internal Carotid Artery Obstruction Using Laser Speckle Flowgraphy. [2018]
Use of the laser speckle flowgraphy in posterior fundus circulation research. [2012]
Relative flow volume, a novel blood flow index in the human retina derived from laser speckle flowgraphy. [2022]
Evaluation of retinal blood flow before and after panretinal photocoagulation using pattern scan laser for diabetic retinopathy. [2018]
Use of laser speckle flowgraphy in ocular blood flow research. [2022]
COMPARISON OF THE RETINAL BLOOD FLOW VELOCITY BETWEEN LASER SPECKLE FLOWGRAPHY AND THE RETINAL FUNCTION IMAGER. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceΒ·Privacy PolicyΒ·CookiesΒ·Security